Account
Chimp&z Inc wins social media mandate for The Derma Co
Mumbai: Merge Infinity Network’s full-service digital advertising alliance, Chimp&z Inc has won the social media marketing mandate for the science-based skincare brand, The Derma Co. The account was won post a multi-agency pitch and will be handled by the agency’s Gurugram office keeping social communications a notch up to drive digital sales.
The agency will also be responsible for social content and product photoshoots, along with creating, managing, and executing end-to-end digital campaigns and strategies.
The Derma Co employs Artificial Intelligence to accurately diagnose consumers’ concerns and their team of dermatologists curate regimes to address the issues. The advanced clinical formulations contain potent ingredients in the right concentration that are safe and effective to heal skin concerns, the brand stated. Chimp&z Inc will craft social media strategies for a science-backed filter-free communication with the consumers to highlight the brand’s vision, innovation, and offerings.
On the association, The Derma Co, co-founder, Ghazal Alagh said, “Chimp&z Inc resonates very well with our approach and through this partnership, we aspire to keep our audience engaged on social media and create a paradigm shift in skincare. We are delighted to partner with Chimp&z Inc for handling strategic and creative responsibilities for The Derma Co.”
Chimp&z Inc, CEO & co-founder, Angad Singh Manchanda said, “We are elated to work on creating powerful social communications for a brand like The Derma Co, which thrives on making the Indian market vocal, and top-notch in skincare solutions. The dedicated team at Chimp&z Inc is excited to work on their social media amplification front and aspires to achieve game-changing results.”
Account
BigTrunk Communications wins digital mandate for Soframycin
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”








